North America Enteral Feeding Formula Market Companies Profiles, Size, Share, Growth, Trends and Forecast to 2026

October 2018 | 100 pages | ID: NF8D72A8AEDEN
Data Bridge Market Research

Abstracts

North America enteral feeding formula market is expected to reach a CAGR of 6.4% in the forecast period of 2019 to 2026. The new market report contains data for historic year 2017, the base year of calculation is 2018 and the forecast period is 2019 to 2026.

Market Segmentation

By Product (Standard Formulas, Disease Specific), Application (Critical Care, Gastroenterology, Oncology, Neurology, Diabetes, Others), Type of Tube Feeding (Gastric Tube Feeding, Nasogastric Tube Feeding, Gastrotomy Tube Feeding, Duodenal or Jejunal Tube Feeding), Stage (Adult, Pediatric), End User (Hospitals, Long Term Care Facilities), Country (Germany, U.S., Canada and Mexico.)

Major growing sectors under the Market Segmentation are as follows:

• In product, the standard formulas segment is dominating the market as the standard formula is rapidly growing in the industry due to its medical application also the composition of the standard formulas are rich in the vitamins, proteins, peptides, which is mostly preferred amongst population for better health and also in the diet concern population.
• In application, the critical care segment is dominating the market critical care segment due to rapid growth in the industry due to the rising number of the patients from the chronic disease, which also leading the consumption of nutritional feeding formulas more towards the patients with the ventilators.
• In type of tube feeding, the gastric tube feeding is dominating the market; the gastric tube feeding segment is rising in the forecast period due to the rising eating disorder in the various reasons leading the bypass route nutritional supplies and with the effortless and painless supply of the nutrients by the gastric route.
• In stage, the adult segment in the market is growing with the highest share and dominating the market due to the growing lifestyle concern and changing diet plans and rising awareness towards the fitness also due to the rising prevalence of chronic diseases amongst adult generation.
• In end user, hospitals are the institutes which are highly preferred by the patients for diagnosis and treatment. The technology is advanced and offers high precise results in the affordable prices which can be done in hospitals than diagnostic centers and specialty clinics.

Key Market Players

The Key Market Players for North America enteral feeding formula market are listed below:

• Abbott
• Nestle
• Meiji Holdings CO., LTD
• B. Braun Melsungen AG
• Danone Nutricia
• Fresenius SE & CO. KGAA
• Global Health Products, Inc
• Hormel Foods, Llc
• Mead Johnson & Company, Llc
• Medline Industries, Inc
• Medtrition, Inc
• Nutritional Medicinals, Llc
• Real Food Blends
• Victus

Contents

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF NORTH AMERICA ENTERAL FEEDING FORMULA MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED
2.2 GEOGRAPHIC SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 RESEARCH METHODOLOGY
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7 DBMR MARKET CHALLENGE MATRIX
2.8 SECONDARY SOURCES
2.9 ASSUMPTIONS

3 MARKET OVERVIEW

3.1 DRIVERS
  3.1.1 RISING NUMBER OF PRETERM BIRTH
  3.1.2 GROWING NUMBER OF CHRONIC DISEASES
  3.1.3 GROWING BUSINESS EXPANSION FOR NUTRITIONAL SUPPLY
  3.1.4 GROWING NEED OF NUTRITIONAL CARE FOR GERIATRIC POPULATION
3.2 RESTRAINTS
  3.2.1 RISK ASSOCIATED WITH THE ENTERAL TUBE FEEDING
  3.2.2 STRICT REGULATION OF USAGE FOR PATIENTS SAFETY
3.3 OPPORTUNITIES
  3.3.1 GROWTH IN HEALTHCARE EXPENDITURE OF DEVELOPING ECONOMIES
3.4 CHALLENGES
  3.4.1 INSUFFICIENT REIMBURSEMENTS POLICIES
  3.4.2 LACK OF TRAINED STAFF

4 EXECUTIVE SUMMARY

5 PREMIUM INSIGHTS

6 NORTH AMERICA ENTERAL FEEDING FORMULA MARKET, BY PRODUCT

6.1 OVERVIEW
6.2 STANDARD FORMULAS
  6.2.1 MONOMERIC
  6.2.2 POLYMERIC
6.3 DISEASE SPECIFIC
  6.3.1 DIABETIC FORMULAS
  6.3.2 RENAL FORMULAS
  6.3.3 HEPATIC FORMULAS
  6.3.4 PULMONARY FORMULAS
  6.3.5 OTHERS

7 NORTH AMERICA ENTERAL FEEDING FORMULA MARKET, BY APPLICATION

7.1 OVERVIEW
7.2 CRITICAL CARE
7.3 GASTROENTEROLOGY
7.4 ONCOLOGY
7.5 NEUROLOGY
7.6 DIABETES
7.7 OTHERS

8 NORTH AMERICA ENTERAL FEEDING FORMULA MARKET, BY TYPE OF TUBE FEEDING

8.1 OVERVIEW
8.2 GASTRIC TUBE FEEDING
8.3 NASOGASTRIC TUBE FEEDING
8.4 GASTROTOMY TUBE FEEDING
8.5 DUODENAL OR JEJUNAL TUBE FEEDING

9 NORTH AMERICA ENTERAL FEEDING FORMULA MARKET, BY STAGE

9.1 OVERVIEW
9.2 ADULT
9.3 PEDIATRIC

10 NORTH AMERICA ENTERAL FEEDING FORMULA MARKET, BY END USER

10.1 OVERVIEW
10.2 HOSPITALS
10.3 LONG TERM CARE FACILITIES
  10.3.1 HOME CARE AGENCIES AND HOSPICES
  10.3.2 NURSING HOMES
  10.3.3 ASSISTED LIVING FACILITIES

11 NORTH AMERICA ENTERAL FEEDING FORMULA MARKET, BY GEOGRAPHY

11.1 NORTH AMERICA
  11.1.1 U.S.
  11.1.2 CANADA
  11.1.3 MEXICO

12 NORTH AMERICA ENTERAL FEEDING FORMULA MARKET, COMPANY LANDSCAPE

12.1 COMPANY SHARE ANALYSIS: NORTH AMERICA

13 COMPANY PROFILE

13.1 ABBOTT
  13.1.1 COMPANY SNAPSHOT
  13.1.2 REVENUE ANALYSIS
  13.1.3 COMPANY SHARE ANALYSIS
  13.1.4 PRODUCT PORTFOLIO
  13.1.5 RECENT DEVELOPMENTS
13.2 NESTLÉ
  13.2.1 COMPANY OVERVIEW
  13.2.2 REVENUE ANALYSIS
  13.2.3 COMPANY SHARE ANALYSIS
  13.2.4 PRODUCT PORTFOLIO
  13.2.5 RECENT DEVELOPMENTS
13.3 MEIJI HOLDINGS CO., LTD.
  13.3.1 COMPANY OVERVIEW
  13.3.2 REVENUE ANALYSIS
  13.3.3 COMPANY SHARE ANALYSIS
  13.3.4 PRODUCT PORTFOLIO
  13.3.5 RECENT DEVELOPMENTS
13.4 B. BRAUN MELSUNGEN AG
  13.4.1 COMPANY SNAPSHOT
  13.4.2 REVENUE ANALYSIS
  13.4.3 COMPANY SHARE ANALYSIS
  13.4.4 PRODUCT PORTFOLIO
  13.4.5 RECENT DEVELOPMENTS
13.5 DANONE NUTRICIA
  13.5.1 COMPANY SNAPSHOT
  13.5.2 GEOGRAPHICAL PRESENCE
  13.5.3 PRODUCT PORTFOLIO
  13.5.4 RECENT DEVELOPMENTS
13.6 FRESENIUS SE & CO. KGAA
  13.6.1 COMPANY SNAPSHOT
  13.6.2 REVENUE ANALYSIS
  13.6.3 PRODUCT PORTFOLIO
  13.6.4 RECENT DEVELOPMENTS
13.7 NORTH AMERICA HEALTH PRODUCTS, INC.
  13.7.1 COMPANY SNAPSHOT
  13.7.2 PRODUCT PORTFOLIO
  13.7.3 RECENT DEVELOPMENT
13.8 HORMEL FOODS, LLC
  13.8.1 COMPANY SNAPSHOT
  13.8.2 GEOGRAPHICAL PRESENCE
  13.8.3 PRODUCT PORTFOLIO
  13.8.4 RECENT DEVELOPMENTS
13.9 MEAD JOHNSON & COMPANY, LLC.
  13.9.1 COMPANY SNAPSHOT
  13.9.2 GEOGRAPHICAL PRESENCE
  13.9.3 PRODUCT PORTFOLIO
  13.9.4 RECENT DEVELOPMENTS
13.10 MEDLINE INDUSTRIES, INC
  13.10.1 COMPANY SNAPSHOT
  13.10.2 GEOGRAPHICAL PRESENCE
  13.10.3 PRODUCT PORTFOLIO
  13.10.4 RECENT DEVELOPMENTS
13.11 MEDTRITION, INC.
  13.11.1 COMPANY SNAPSHOT
  13.11.2 PRODUCT PORTFOLIO
  13.11.3 NO RECENT DEVELOPMENTS
13.12 NUTRITIONAL MEDICINALS, LLC
  13.12.1 COMPANY SNAPSHOT
  13.12.2 GEOGRAPHICAL PRESENCE
  13.12.3 PRODUCT PORTFOLIO
  13.12.4 NO RECENT DEVELOPMENTS
13.13 REAL FOOD BLENDS
  13.13.1 COMPANY SNAPSHOT
  13.13.2 PRODUCT PORTFOLIO
  13.13.3 RECENT DEVELOPMENTS
13.14 VICTUS
  13.14.1 COMPANY SNAPSHOT
  13.14.2 PRODUCT PORTFOLIO
  13.14.3 RECENT DEVELOPMENTS

14 RELATED REPORTS

List Of Tables

LIST OF TABLES

Table 1 NORTH AMERICA ENTERAL FEEDING FORMULA MARKET, BY PRODUCT, 2017-2026 (USD MILLION)
Table 2 NORTH AMERICA STANDARD FORMULAS IN ENTERAL FEEDING FORMULA MARKET, BY PRODUCT, BY REGION, 2017-2026 (USD MILLION)
Table 3 NORTH AMERICA STANDARD FORMULA IN ENTERAL FEEDING FORMULA MARKET, BY PRODUCT, 2017-2026 (USD MILLION)
Table 4 NORTH AMERICA DISEASE SPECIFIC IN ENTERAL FEEDING FORMULA MARKET, BY PRODUCT, BY REGION, 2017-2026 (USD MILLION)
Table 5 NORTH AMERICA DISEASE SPECIFIC FORMULAS IN ENTERAL FEEDING FORMULA MARKET, BY PRODUCT, 2017-2026 (USD MILLION)
Table 6 NORTH AMERICA ENTERAL FEEDING FORMULA MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
Table 7 NORTH AMERICA CRITICAL CARE IN ENTERAL FEEDING FORMULA MARKET, BY APPLICATION, BY REGION, 2017-2026 (USD MILLION)
Table 8 NORTH AMERICA GASTROENTEROLOGY IN ENTERAL FEEDING FORMULA MARKET, BY APPLICATION, BY REGION, 2017-2026 (USD MILLION)
Table 9 NORTH AMERICA ONCOLOGY IN ENTERAL FEEDING FORMULA MARKET, BY APPLICATION, BY REGION, 2017-2026 (USD MILLION)
Table 10 NORTH AMERICA NEUROLOGY IN ENTERAL FEEDING FORMULA MARKET, BY APPLICATION, BY REGION, 2017-2026 (USD MILLION)
Table 11 NORTH AMERICA DIABETES IN ENTERAL FEEDING FORMULA MARKET, BY APPLICATION, BY REGION, 2017-2026 (USD MILLION)
Table 12 NORTH AMERICA OTHERS IN ENTERAL FEEDING FORMULA MARKET, BY APPLICATION, BY REGION, 2017-2026 (USD MILLION)
Table 13 NORTH AMERICA ENTERAL FEEDING FORMULA MARKET, BY TYPE OF TUBE FEEDING, 2017-2026 (USD MILLION)
Table 14 NORTH AMERICA GASTRIC TUBE FEEDING IN ENTERAL FEEDING FORMULA MARKET, BY TUBE OF FEEDING, BY REGION, 2017-2026 (USD MILLION)
Table 15 NORTH AMERICA NASOGASTRIC TUBE FEEDING IN ENTERAL FEEDING FORMULA MARKET, BY TUBE OF FEEDING, BY REGION, 2017-2026 (USD MILLION)
Table 16 NORTH AMERICA GASTROSTOMY TUBE FEEDING IN ENTERAL FEEDING FORMULA MARKET, BY TUBE OF FEEDING, BY REGION, 2017-2026 (USD MILLION)
Table 17 NORTH AMERICA DUODENAL OR JEJUNAL TUBE FEEDING IN ENTERAL FEEDING FORMULA MARKET, BY TUBE OF FEEDING, BY REGION, 2017-2026 (USD MILLION)
Table 18 NORTH AMERICA ENTERAL FEEDING FORMULA MARKET, BY STAGE, 2017-2026 (USD MILLION)
Table 19 NORTH AMERICA ADULT IN ENTERAL FEEDING FORMULA MARKET, BY STAGE, BY REGION, 2017-2026 (USD MILLION)
Table 20 NORTH AMERICA PEDIATRIC IN ENTERAL FEEDING FORMULA MARKET, BY STAGE, BY REGION, 2017-2026 (USD MILLION)
Table 21 NORTH AMERICA ENTERAL FEEDING FORMULA MARKET, BY END USER, 2017-2026 (USD MILLION)
Table 22 NORTH AMERICA HOSPITALS IN ENTERAL FEEDING FORMULA MARKET, BY END USER, BY REGION, 2017-2026 (USD MILLION)
Table 23 NORTH AMERICA LONG TERM CARE FACILITIES IN ENTERAL FEEDING FORMULA MARKET, BY END USER, 2017-2026 (USD MILLION)
Table 24 NORTH AMERICA LONG TERM CARE FACILITIES IN ENTERAL FEEDING FORMULA MARKET, BY END USER, BY REGION, 2017-2026 (USD MILLION)
Table 25 NORTH AMERICA ENTERAL FEEDING FORMULA MARKET, BY COUNTRY, 2017-2026(USD MILLION)
Table 26 NORTH AMERICA ENTERAL FEEDING FORMULA MARKET, BY PRODUCT, 2017-2026(USD MILLION)
Table 27 NORTH AMERICA STANDARD FORMULA IN ENTERAL FEEDING FORMULA MARKET, BY PRODUCT, 2017-2026 (USD MILLION)
Table 28 NORTH AMERICA DISEASE SPECIFIC FORMULAS IN ENTERAL FEEDING FORMULA MARKET, BY PRODUCT, 2017-2026 (USD MILLION)
Table 29 NORTH AMERICA ENTERAL FEEDING FORMULA MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
Table 30 NORTH AMERICA ENTERAL FEEDING FORMULA MARKET, BY TYPE OF TUBE FEEDING 2017-2026 (USD MILLION)
Table 31 NORTH AMERICA ENTERAL FEEDING FORMULA MARKET, BY STAGE, 2017-2026 (USD MILLION)
Table 32 NORTH AMERICA ENTERAL FEEDING FORMULA MARKET, BY END USER, 2017-2026 (USD MILLION)
Table 33 NORTH AMERICA LONG TERM CARE FACILITIES IN ENTERAL FEEDING FORMULA MARKET, BY END USER, 2017-2026 (USD MILLION)
Table 34 U.S. ENTERAL FEEDING FORMULA MARKET, BY PRODUCT, 2017-2026(USD MILLION)
Table 35 U.S. STANDARD FORMULA IN ENTERAL FEEDING FORMULA MARKET, BY PRODUCT, 2017-2026 (USD MILLION)
Table 36 U.S. DISEASE SPECIFIC FORMULAS IN ENTERAL FEEDING FORMULA MARKET, BY PRODUCT, 2017-2026 (USD MILLION)
Table 37 U.S. ENTERAL FEEDING FORMULA MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
Table 38 U.S. ENTERAL FEEDING FORMULA MARKET, BY TYPE OF TUBE FEEDING 2017-2026 (USD MILLION)
Table 39 U.S. ENTERAL FEEDING FORMULA MARKET, BY STAGE, 2017-2026 (USD MILLION)
Table 40 U.S. ENTERAL FEEDING FORMULA MARKET, BY END USER, 2017-2026 (USD MILLION)
Table 41 U.S. LONG TERM CARE FACILITIES IN ENTERAL FEEDING FORMULA MARKET, BY END USER, 2017-2026 (USD MILLION)
Table 42 CANADA ENTERAL FEEDING FORMULA MARKET, BY PRODUCT, 2017-2026(USD MILLION)
Table 43 CANADA STANDARD FORMULA IN ENTERAL FEEDING FORMULA MARKET, BY PRODUCT, 2017-2026 (USD MILLION)
Table 44 CANADA DISEASE SPECIFIC FORMULAS IN ENTERAL FEEDING FORMULA MARKET, BY PRODUCT, 2017-2026 (USD MILLION))
Table 45 CANADA ENTERAL FEEDING FORMULA MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
Table 46 CANADA ENTERAL FEEDING FORMULA MARKET, BY TYPE OF TUBE FEEDING 2017-2026 (USD MILLION)
Table 47 CANADA ENTERAL FEEDING FORMULA MARKET, BY STAGE, 2017-2026 (USD MILLION)
Table 48 CANADA ENTERAL FEEDING FORMULA MARKET, BY END USER, 2017-2026 (USD MILLION)
Table 49 CANADA LONG TERM CARE FACILITIES IN ENTERAL FEEDING FORMULA MARKET, BY END USER, 2017-2026 (USD MILLION)
Table 50 MEXICO ENTERAL FEEDING FORMULA MARKET, BY PRODUCT, 2017-2026(USD MILLION)
Table 51 MEXICO STANDARD FORMULA IN ENTERAL FEEDING FORMULA MARKET, BY PRODUCT, 2017-2026 (USD MILLION)
Table 52 MEXICO DISEASE SPECIFIC FORMULAS IN ENTERAL FEEDING FORMULA MARKET, BY PRODUCT, 2017-2026 (USD MILLION)
Table 53 MEXICO ENTERAL FEEDING FORMULA MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
Table 54 MEXICO ENTERAL FEEDING FORMULA MARKET, BY TYPE OF TUBE FEEDING 2017-2026 (USD MILLION)
Table 55 MEXICO ENTERAL FEEDING FORMULA MARKET, BY STAGE, 2017-2026 (USD MILLION)
Table 56 MEXICO ENTERAL FEEDING FORMULA MARKET, BY END USER, 2017-2026 (USD MILLION)
Table 57 MEXICO LONG TERM CARE FACILITIES IN ENTERAL FEEDING FORMULA MARKET, BY END USER, 2017-2026 (USD MILLION)

List Of Figures

LIST OF FIGURES

Figure 1 NORTH AMERICA ENTERAL FEEDING FORMULA MARKET: SEGMENTATION
Figure 2 NORTH AMERICA ENTERAL FEEDING FORMULA MARKET: DATA TRIANGULATION
Figure 3 NORTH AMERICA ENTERAL FEEDING FORMULA MARKET: DROC ANALYSIS
Figure 4 NORTH AMERICA ENTERAL FEEDING FORMULA MARKET:BOTTOM UP APPROACH
Figure 5 NORTH AMERICA ENTERAL FEEDING FORMULA MARKET:TOP DOWN APPROACH
Figure 6 NORTH AMERICA ENTERAL FEEDING FORMULA MARKET: INTERVIEW DEMOGRAPHICS
Figure 7 NORTH AMERICA ENTERAL FEEDING FORMULA MARKET: THE MARKET CHALLENGE MATRIX
Figure 8 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF NORTH AMERICA ENTERAL FEEDING FORMULA MARKET
Figure 9 NUMBER OF PRETERM BIRTHS IN FEW COUNTRIES, 2018
Figure 10 TOTAL POPULATION OF AGES 65 AND ABOVE (% OF TOTAL) IN 2015 & 2016
Figure 11 HEALTH EXPENDITURE PER CAPITA IN PPP INTERNATIONAL
Figure 12 NORTH AMERICA ENTERAL FEEDING FORMULA MARKET: SEGMENTATION
Figure 13 NORTH AMERICA IS ANTICIPATED TO DOMINATE THE ENTERAL FEEDING FORMULA MARKET AND ASIA PACIFIC IS ESTIMATED TO BE INCREASING WITH THE STRONG CAGR IN THE FORECAST PERIOD FROM 2019 TO 2026
Figure 14 MAJOR FACTOR DRIVING THE GROWTH OF THIS MARKET ARE RISING NUMBER OF PRETERM BIRTH, GROWING NUMBER OF CHRONIC DISEASES, GROWING BUSINESS EXPANSION FOR NUTRITIONAL SUPPLY AND GROWING NEED OF NUTRITIONAL CARE FOR GERIATRIC POPULATION EXPECTED TO DRIVE THE MRKET FOR NORTH AMERICA ENTERAL FEEDING FORMULA MARKET IN THE FORECAST PERIOD 2019 TO 2026
Figure 15 PRODUCT SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA ENTERAL FEEDING FORMULA MARKET IN 2019 & 2026
Figure 16 NORTH AMERICA ENTERAL FEEDING FORMULA MARKET: BY PRODUCT, 2018
Figure 17 NORTH AMERICA ENTERAL FEEDING FORMULA MARKET: BY APPLICATION, 2018
Figure 18 NORTH AMERICA ENTERAL FEEDING FORMULA MARKET: BY TYPE OF TUBE FEEDING, 2018
Figure 19 NORTH AMERICA ENTERAL FEEDING FORMULA MARKET: BY STAGE, 2018
Figure 20 NORTH AMERICA ENTERAL FEEDING FORMULA MARKET: BY END USER, 2018
Figure 21 NORTH AMERICA ENTERAL FEEDING FORMULA MARKET SNAPSHOT (2018)
Figure 22 NORTH AMERICA ENTERAL FEEDING FORMULA MARKET: BY GEOGRAPHY (2018)
Figure 23 NORTH AMERICA ENTERAL FEEDING FORMULA MARKET: BY GEOGRAPHY (2019 AND 2026)
Figure 24 NORTH AMERICA ENTERAL FEEDING FORMULA MARKET: BY COUNTRY (2018 & 2026)
Figure 25 NORTH AMERICA ENTERAL FEEDING FORMULA MARKET: BY PRODUCT(2019 - 2026)
Figure 26 NORTH AMERICA ENTERAL FEEDING FORMULA MARKET: COMPANY SHARE 2018 (%)